Sequent Scientific Ltd.

NSE: SEQUENT | BSE: 512529 | ISIN: INE807F01027 |Industry: Pharmaceuticals
|Expensive Star
152.30 -1.95 (-1.26%)
NSE Oct 22, 2020 14:09 PM
Volume: 709.9K

Sequent Scientific Ltd.    
29 Jan 2020
Nirmal Bang Institutional
Sequent Scientific or SSL's 3QFY20 revenue at Rs3,164mn was higher than our estimate by 7.4%. Revenue grew by 17% YoY and was led by growth in both API and formulation sales. API sales grew by 17.8% YoY and the formulations business grew by 16.5% YoY. Growth in API sales (20 -30%) should sustain at least until the end of FY21 as the company continues to build sales in regulated markets. The company is investing to implement additional API capacities with an objective to sustain growth trajectory...
Promoters released all pledges in Sep 2020 qtr.
More from Sequent Scientific Ltd.